Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-26T12:54:54.188Z Has data issue: false hasContentIssue false
  • English
  • Français

The effect of low doses of betaine on plasma homocysteine in healthy volunteers

Published online by Cambridge University Press:  09 March 2007

Georg Alfthan ,
Kaisa Tapani ,
Katja Nissinen ,
Janna Saarela  and
Antti Aro
Georg Alfthan*
Affiliation:
Departments of Health and Functional Capacity, National Public Health Institute (KTL), Helsinki, Finland
Kaisa Tapani
Affiliation:
Oy Sinebrychoff Ab, Kerava, Finland
Katja Nissinen
Affiliation:
Departments of Epidemiology and Health PromotionNational Public Health Institute (KTL), Helsinki, Finland
Janna Saarela
Affiliation:
Departments of Molecular Medicine, National Public Health Institute (KTL), Helsinki, Finland
Antti Aro
Affiliation:
Departments of Health and Functional Capacity, National Public Health Institute (KTL), Helsinki, Finland
*
*Corresponding author: Dr Georg Alfthan, fax +3589 47448695, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Homocysteine is a risk factor for vascular diseases, and lowering of plasma total homocysteine (tHcy) may be beneficial for health. Homocysteine can be remethylated to methionine by betaine–homocysteine methyltransferase using betaine (2(N,N,N-trimethyl)glycine) as methyl donor. A dose of 6 g betaine/d has been used in the treatment of homocystinuria, but data on the dose–response are scarce. Thirty-four healthy men and women were supplied with doses of 1, 3 and 6 g betaine and then with 6 g betaine + 1 mg folic acid for four consecutive 1-week periods. The mean plasma tHcy concentration decreased by 1·1 (NS), 10·0 and 14·0 % (P<0·001) after supplementation with 1, 3 and 6 g betaine respectively. A further decrease in plasma tHcy by 5 % (P<0·01) was achieved by combining 1 mg folic acid with the 6 g betaine dose. Plasma betaine increased from 31 (SD 13) to 255 (SD 136) μmol/l in a dose-dependent manner (R2 0·97). We conclude that plasma tHcy is lowered rapidly and significantly by 3 or 6 g betaine/d in healthy men and women.

Keywords

BetaineHomocysteineDose–responseFolic acid
Type
Research Article
Information
British Journal of Nutrition , Volume 92 , Issue 4 , October 2004 , pp. 665 - 669
Copyright
Copyright © The Nutrition Society 2004

References

Alfthan, G, Laurinen, M, Valsta, L, Pastinen, T & Aro, A (2003) Plasma folate, folate intake and homocysteine status in a random Finnish population. Eur J Clin Nutr 57, 81–88CrossRefGoogle Scholar
Bell, GI, Karam, JH & Rutter, WJ (1981) Polymorphic DNA region adjacent to the 5' end of the human insulin gene. Proc Natl Acad Sci 78, 5759–5763CrossRefGoogle Scholar
Brouwer, IA, van Dusseldorp, M, Thomas, CMG, Duran, M, Hautvast, JGAJ, Eskes, TKAB & Steegers-Theunissen, RPM (1999) Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Am J Clin Nutr 69, 99–104CrossRefGoogle ScholarPubMed
Brouwer, IA, Verhoef, P & Urgert, R (2000) Betaine supplementation and plasma homocysteine in healthy volunteers. Arch Int Med 160, 2546–2547CrossRefGoogle ScholarPubMed
Eikelboom, JW, Lonn, E, Genest, J, Hankey, G & Yusuf, S (1999) Homocysteine and cardiovascular disease: a critical review of the epidemiological evidence. Ann Int Med 131, 363–375CrossRefGoogle Scholar
Finnish Nutritional Recommendations (1998) www.mmm.fi/ravitsemusneuvoltelukunta/nutrec98.pdf (The recommendations are in English).Google Scholar
Gudnason, V, Stansbie, D, Scott, J, Bowron, A, Nicaud, V, Humphries, S, on, behalf, of, the & EARS, group (1998) C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. Atherosclerosis 136, 347–354CrossRefGoogle ScholarPubMed
Homocysteine Lowering Trialists' Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Br Med J 316, 894–898CrossRefGoogle Scholar
Knekt, P, Reunanen, A, Alfthan, G, Heliövaara, M, Rissanen, H, Marniemi, J & Aromaa, A (2001) Hyperhomocysteinemia – a risk factor or a consequence of coronary heart disease? Arch Int Med 161, 1589–1594CrossRefGoogle ScholarPubMed
Laryea, MD, Steinhagen, F, Pawliczek, S & Wendel, U (1998) Simple method for the routine determination of betaine and N,N-dimethylglycine in blood and urine. Clin Chem 44, 1937–1941CrossRefGoogle Scholar
Matthews, A, Johnson, TN, Rostami-Hodjegan, A, Chakrapani, A, Wraith, JE, Moat, SJ, Bonham, JR & Tucker, JT (2002) An indirect response model of homocysteine supression by betaine:optimising the dosage regimen of betaine in homocystinuria. Br J Clin Pharmacol 54, 140–146CrossRefGoogle Scholar
Möller, J, Rasmussen, K & Christensen, L (1999) External quality assessment of methylmalonic and total homocysteine. Clin Chem 45, 1536–1542CrossRefGoogle ScholarPubMed
Mudd, SH, Levy, HL & Skovby, F (1995) Disorders of transsulfuration. In The Metabolic and Molecular Basis of Inherited Disease, 7th ed. pp. 1279–1327 [Scriver, CR, Beaudet, AL, Sly, WS and Valle, D, editors]. New York: McGraw-Hill.Google Scholar
Olthof, MR, van Vliet, T, Boelsma, E & Verhoef, P (2003) Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. J Nutr 133, 4135–4138CrossRefGoogle ScholarPubMed
Ovaskainen, ML (2001) Fineli ® Elintarvikkeiden Koostumustietopankki (National Food Composition Database). www.ktl.fi/fineli (in Finnish).Google Scholar
Prinz-Langenohl, R, Brönstrup, A, Thorand, B, Hages, M & Pietrzik, K (1999) Availability of food folate in humans. J Nutr 29, 913–916CrossRefGoogle Scholar
Pullin, CH, Ashfield-Watt, PAL, Burr, ML, et al. (2001) Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype. J Am Coll Cardiol 38, 1799–1805CrossRefGoogle Scholar
Schwab, U, Törrönen, A, Toppinen, L, Alfthan, G, Aro, A & Uusitupa, M (2002) Betaine supplementation with a low calorie diet decreases plasma homocysteine concentrations but does not affect body weight, body composition, resting energy expenditure or serum lipid concentrations. Am J Clin Nutr 76, 961–967CrossRefGoogle Scholar
Schwahn, BC, Hafner, D, Hohfeld, T, Balkenhol, N, Laryea, MD & Wendel, U (2003) Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. Br J Clin Pharmacol 55, 6–13CrossRefGoogle ScholarPubMed
Steenge, GR, Verhoef, P & Katan, MB (2003) Betaine supplementation lowers plasma homocysteine in healthy men and women. J Nutr 133, 1291–1295CrossRefGoogle ScholarPubMed
Ubbink, JB, Vermaak, WJH & Bissbort, S (1991) Rapid high-performance liquid chromatography assay for total homocysteine levels in human serum. J Chromatogr 565, 441–446CrossRefGoogle ScholarPubMed
Ubbink, JB, Vermaak, WJH, van der Merwe, A, Becker, PJ, Delport, R & Potgieter, HC (1994) Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 124, 1927–1933CrossRefGoogle ScholarPubMed
Van Guldener, C, Janssen, MJF, deMeer, K, Donker, AJM & Stehouwer, CDA (1999) Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients. J Int Med 245, 175–183CrossRefGoogle ScholarPubMed
Wilcken, DEL & Wilcken, B (1997) The natural history of vascular disease in homocystinuria and effects of treatment. J Inherit Metab Dis 20, 295–300CrossRefGoogle ScholarPubMed
Wilcken, DEL, Wilcken, B, Dudman, NPB & Tyrrell, PA (1983) Homocystinuria – the effects of betaine in the treatment of patients not responsive to pyridoxine. N Engl J Med 309, 448–453CrossRefGoogle Scholar
Zeisel, SH, Mar, MH, Howe, JC & Holden, JM (2003) Concentrations of choline-containing compounds and betaine in common foods. J Nutr 133, 1302–1307CrossRefGoogle ScholarPubMed